Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

AAV gene therapy in early life provides lasting HIV protection in primates—offering hope for pediatric HIV intervention in ...

Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...